HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Henney hearing follow-up

This article was originally published in The Rose Sheet

Executive Summary

Senate Labor & Human Resources committee member Dan Coats (R- Ind.) asks Commissioner-nominee Jane Henney, MD, to "reconcile" her position on supporting industry/agency collaboration with the recent FDA announcement that the agency will not share information or solicit comments regarding implementation of the FDA Modernization Act. In a separate series of follow-up questions, Committee Chairman James Jeffords (R-Vt.) asks Henney to explain what she meant by "enhancing FDA's science base" during her testimony. Henney appeared before the committee Sept. 2 ("The Rose Sheet" Sept. 7, p. 10)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel